Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Keiichi, Kosaka"'
Publikováno v:
Case Reports in Gastroenterology, Vol 3, Iss 2, Pp 138-146 (2009)
Abdominal and pelvic abscesses occur in approximately 10–30% of Crohn’s disease patients during the course of the disease; most of these abscesses have an enteric communication. For this condition, percutaneous abscess drainage (PAD) rather than
Externí odkaz:
https://doaj.org/article/e74fca41303147ed85dcd4f19d27c20a
Autor:
Toshiya Inaba, Hiroshi Aikata, Masataka Tsuge, Nobuhiko Hiraga, Yoji Honda, Hiromi Abe, Kazuaki Chayama, Akinori Kanai, Fiona McPhee, Tomokazu Kawaoka, Daiki Miki, Eisuke Murakami, Hirotaka Matsui, Hidenori Ochi, Shoichi Takahashi, C. Nelson Hayes, Michio Imamura, Keiichi Kosaka, Atsushi Ono
Publikováno v:
Antimicrobial Agents and Chemotherapy. 58:2105-2112
Direct-acting antivirals (DAAs) are either part of the current standard of care or are in advanced clinical development for the treatment of patients chronically infected with hepatitis C virus (HCV) genotype 1, but concern exists with respect to the
Autor:
Keiichi Kosaka, Satoshi Yoshimi, Masahiro Serikawa, Tomoyuki Minami, Masanobu Yukutake, Akihito Okazaki, Yasutaka Ishii, Kazuaki Chayama, Teruo Mouri, Takashi Ishigaki, Tamito Sasaki
Publikováno v:
Journal of Gastroenterology and Hepatology. 29:653-659
Background and Aim Despite the benefits of endoscopic nasobiliary drainage (NBD) in endoscopic retrograde cholangiopancreatography (ERCP), post-ERCP pancreatitis (PEP) and nose/throat discomfort can result. We aimed to determine whether the use of a
Autor:
Akihito Okazaki, Kenichiro Uemura, Tomoyuki Minami, Tamito Sasaki, Tomofumi Tsuboi, Yasutaka Ishii, Satoshi Yoshimi, Teruo Mouri, Masanobu Yukutake, Kazuaki Chayama, Koji Arihiro, Noriyuki Shiroma, Keiichi Kosaka, Akinori Shimizu, Yoshiaki Murakami, Masahiro Serikawa, Takashi Ishigaki
Publikováno v:
Suizo. 29:74-82
Autor:
Masahiro Serikawa, Tomoyuki Minami, Akihito Okazaki, Keiichi Kosaka, Teruo Mouri, Akinori Shimizu, Yasutaka Ishii, Tamito Sasaki, Satoshi Yoshimi, Takashi Ishigaki, Masanobu Yukutake, Tomofumi Tsuboi, Kazuaki Chayama
Publikováno v:
International Journal of Oncology. 43:1073-1079
Cholangiocarcinoma (CCA) occurs frequently in primary sclerosing cholangitis (PSC). Cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase-1 (mPGES-1) induced by inflammation are believed to mediate prostaglandin E2 (PGE2) production thereb
Autor:
Keiichi Kosaka, Keizo Tanitame, K. Arihiro, Masahiro Serikawa, Kazuaki Chayama, Yasutaka Ishii, Tomoyuki Minami, Teruo Mouri, Satoshi Yoshimi, Michihiro Kamigaki, Akihito Okazaki, Kenso Kobayashi, Tamito Sasaki, Takashi Ishigaki, Masanobu Yukutake
Publikováno v:
Suizo. 27:608-616
Publikováno v:
European Journal of Pharmacology. 568:260-268
Mitogen-activated protein kinase (MAPK)-mediated signal transduction pathways convert signals by extracellular stimulation into a variety of cellular functions. However, the roles of MAPKs in neutrophils are not well understood. To elucidate the temp
Autor:
Yasutaka, Ishii, Tamito, Sasaki, Masahiro, Serikawa, Kenso, Kobayashi, Michihiro, Kamigaki, Tomoyuki, Minami, Akihito, Okazaki, Masanobu, Yukutake, Takashi, Ishigaki, Keiichi, Kosaka, Teruo, Mouri, Satoshi, Yoshimi, Kazuaki, Chayama
Publikováno v:
Hepato-gastroenterology. 61(131)
Primary sclerosing cholangitis (PSC) is often complicated by cholangiocarcinoma (CCA); thus, early detection of CCA is an important way to improve PSC prognosis.In a retrospective study, 23 cases of PSC were included. Seven cases were complicated by
Autor:
Takashi, Ishigaki, Tamito, Sasaki, Masahiro, Serikawa, Kenso, Kobayashi, Michihiro, Kamigaki, Tomoyuki, Minami, Akihito, Okazaki, Masanobu, Yukutake, Yasutaka, Ishii, Keiichi, Kosaka, Teruo, Mouri, Satoshi, Yoshimi, Kazuaki, Chayama
Publikováno v:
Hepato-gastroenterology. 62(138)
The purpose of this study was to evaluate the relationship between prophylactic antibiotic use and complications following endoscopic retrograde cholangiopancreatography (ERCP).We retrospectively evaluated 605 consecutive patients who underwent ERCP
Autor:
Hirotaka Matsui, Akinori Kanai, Daiki Miki, Eisuke Murakami, Hidenori Ochi, Hiromi Abe, Masataka Tsuge, Nobuhiko Hiraga, Kazuaki Chayama, Clair Nelson Hayes, Tomokazu Kawaoka, Michio Imamura, Keiichi Kosaka, Toshiya Inaba, Hiroshi Aikata, Satoshi Yoshimi
Publikováno v:
Journal of viral hepatitis. 22(2)
Summary Daclatasvir (DCV) and asunaprevir (ASV) are NS5A and NS3 protease-targeted antivirals respectively, currently under development for the treatment of chronic hepatitis C virus (HCV) infection. We analysed the relationship between pre-existing